{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:22:06Z","timestamp":1791901326192,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23Y11905000"],"award-info":[{"award-number":["23Y11905000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271834"],"award-info":[{"award-number":["82271834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC22024245"],"award-info":[{"award-number":["SHDC22024245"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"name":"clinical research project of zhongshan hospital","award":["ZSLCYJ202307"],"award-info":[{"award-number":["ZSLCYJ202307"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04434-y","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:28:39Z","timestamp":1762957719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["THBS1high macrophages promote aortic aneurysm formation by orchestrating an inflammatory and smooth muscle cell phenotypic transition program in vascular Beh\u00e7et\u2019s disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Xianting","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"6","key":"4434_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","volume":"17","author":"A Greco","year":"2018","unstructured":"Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, et al. Behcet\u2019s disease: New insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018;17(6):567\u201375.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4434_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13075-021-02429-7","volume":"23","author":"J Zou","year":"2021","unstructured":"Zou J, Luo JF, Shen Y, Cai JF, Guan JL. Cluster analysis of phenotypes of patients with Behcet\u2019s syndrome: a large cohort study from a referral center in China. Arthritis Res Ther. 2021;23(1):45.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4434_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41584-022-00880-7","volume":"19","author":"A Bettiol","year":"2023","unstructured":"Bettiol A, Alibaz-Oner F, Direskeneli H, Hatemi G, Saadoun D, Seyahi E, et al. Vascular Behcet syndrome: from pathogenesis to treatment. Nat Rev Rheumatol. 2023;19(2):111\u201326.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"4434_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","volume":"14","author":"H Yazici","year":"2018","unstructured":"Yazici H, Seyahi E, Hatemi G, Yazici Y. Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14(2):107\u201319.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4434_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jvsv.2016.01.003","volume":"4","author":"F Alibaz-Oner","year":"2016","unstructured":"Alibaz-Oner F, Aldag B, Aldag M, Unal AU, Mutis A, Toptas T, et al. Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behcet\u2019s disease. J Vasc Surg Venous Lymphat Disord. 2016;4(3):301\u20136.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"1","key":"4434_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MD.0b013e318242ff37","volume":"91","author":"E Seyahi","year":"2012","unstructured":"Seyahi E, Melikoglu M, Akman C, Hamuryudan V, Ozer H, Hatemi G, et al. Pulmonary artery involvement and associated lung disease in Behcet disease: a series of 47 patients. Medicine (Baltimore). 2012;91(1):35\u201348.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"4434_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11739-018-1991-y","volume":"14","author":"G Emmi","year":"2019","unstructured":"Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C, et al. Vascular Behcet\u2019s syndrome: an update. Intern Emerg Med. 2019;14(5):645\u201352.","journal-title":"Intern Emerg Med"},{"issue":"5","key":"4434_CR8","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.jvs.2020.01.076","volume":"72","author":"J Gaudric","year":"2020","unstructured":"Gaudric J, Jayet J, Saadoun D, Couture T, Ferfar Y, Davaine JM, et al. Factors influencing the recurrence of arterial involvement after surgical repair in Behcet disease. J Vasc Surg. 2020;72(5):1761\u20139.","journal-title":"J Vasc Surg"},{"issue":"26","key":"4434_CR9","doi-asserted-by":"publisher","first-page":"e2204289119","DOI":"10.1073\/pnas.2204289119","volume":"119","author":"W Zheng","year":"2022","unstructured":"Zheng W, Wang X, Liu J, Yu X, Li L, Wang H, et al. Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behcet\u2019s disease. Proc Natl Acad Sci U S A. 2022;119(26):e2204289119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4434_CR10","doi-asserted-by":"crossref","unstructured":"Chang L, Zheng Z, Zou Q, Zhong B, Chen C, Cheng X, et al. Single cell Transcriptome and T cell Repertoire Mapping of the Mechanistic Signatures and T cell Trajectories Contributing to Vascular and Dermal Manifestations of Behcet\u2019s Disease. bioRxiv. 2022:2022.03.22.485251.","DOI":"10.1101\/2022.03.22.485251"},{"issue":"8","key":"4434_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nm0810-851","volume":"16","author":"W Ruf","year":"2010","unstructured":"Ruf W, Ruggeri ZM. Neutrophils release brakes of coagulation. Nat Med. 2010;16(8):851\u20132.","journal-title":"Nat Med"},{"issue":"1","key":"4434_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-023-01325-7","volume":"8","author":"J Gao","year":"2023","unstructured":"Gao J, Cao H, Hu G, Wu Y, Xu Y, Cui H, et al. The mechanism and therapy of aortic aneurysms. Signal Transduct Target Ther. 2023;8(1):55.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4434_CR13","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.4049\/jimmunol.0803164","volume":"183","author":"W Xiong","year":"2009","unstructured":"Xiong W, MacTaggart J, Knispel R, Worth J, Persidsky Y, Baxter BT. Blocking TNF-alpha attenuates aneurysm formation in a murine model. J Immunol. 2009;183(4):2741\u20136.","journal-title":"J Immunol"},{"issue":"4","key":"4434_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/eurheartj\/ehad534","volume":"45","author":"Y Luo","year":"2024","unstructured":"Luo Y, Luo J, An P, Zhao Y, Zhao W, Fang Z, et al. The activator protein-1 complex governs a vascular degenerative transcriptional programme in smooth muscle cells to trigger aortic dissection and rupture. Eur Heart J. 2024;45(4):287\u2013305.","journal-title":"Eur Heart J"},{"key":"4434_CR15","doi-asserted-by":"publisher","first-page":"852297","DOI":"10.3389\/fimmu.2022.852297","volume":"13","author":"L Hirahara","year":"2022","unstructured":"Hirahara L, Takase-Minegishi K, Kirino Y, Iizuka-Iribe Y, Soejima Y, Yoshimi R, et al. The roles of monocytes and macrophages in Behcet\u2019s disease with focus on M1 and M2 Polarization. Front Immunol. 2022;13:852297.","journal-title":"Front Immunol"},{"issue":"1","key":"4434_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13075-022-02938-z","volume":"24","author":"X Wu","year":"2022","unstructured":"Wu X, Wang Z, Shi J, Yu X, Li C, Liu J, et al. Macrophage polarization toward M1 phenotype through NF-kappaB signaling in patients with Behcet\u2019s disease. Arthritis Res Ther. 2022;24(1):249.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"4434_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Behcet's D","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Behcet\u2019s D. The international criteria for Behcet\u2019s disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338\u201347.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"4434_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","volume":"43","author":"G Lawton","year":"2004","unstructured":"Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet\u2019s disease activity index. Rheumatology (Oxford). 2004;43(1):73\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"4434_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4161\/mabs.21227","volume":"4","author":"P Kanakaraj","year":"2012","unstructured":"Kanakaraj P, Puffer BA, Yao XT, Kankanala S, Boyd E, Shah RR, et al. Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis. MAbs. 2012;4(5):600\u201313.","journal-title":"MAbs"},{"issue":"3","key":"4434_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/art.37797","volume":"65","author":"NB Binder","year":"2013","unstructured":"Binder NB, Puchner A, Niederreiter B, Hayer S, Leiss H, Bluml S, et al. Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis. Arthritis Rheum. 2013;65(3):608\u201317.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4434_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3109\/09273940903521964","volume":"18","author":"S Johnsen-Soriano","year":"2010","unstructured":"Johnsen-Soriano S, Sancho-Tello M, Arnal E, Diaz-Llopis M, Navea A, Miranda M, et al. Comparison of the acute effects of anti-TNF-alpha drugs on a uveitis experimental model. Ocul Immunol Inflamm. 2010;18(3):208\u201315.","journal-title":"Ocul Immunol Inflamm"},{"key":"4434_CR22","doi-asserted-by":"crossref","unstructured":"Martinez-Fernandez de la Camara C, Hernandez-Pinto AM, Olivares-Gonzalez L, Cuevas-Martin C, Sanchez-Arago M, Hervas D, et al. Adalimumab Reduces Photoreceptor Cell Death in A Mouse Model of Retinal Degeneration. Sci Rep. 2015;5:11764.","DOI":"10.1038\/srep11764"},{"key":"4434_CR23","doi-asserted-by":"publisher","first-page":"646516","DOI":"10.3389\/fimmu.2021.646516","volume":"12","author":"X Kong","year":"2021","unstructured":"Kong X, Xu M, Cui X, Ma L, Cheng H, Hou J, et al. Potential role of macrophage phenotypes and CCL2 in the pathogenesis of Takayasu arteritis. Front Immunol. 2021;12:646516.","journal-title":"Front Immunol"},{"issue":"1","key":"4434_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang S, Ma J, Chen Z, Song G, Rao D, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 2022;12(1):134\u201353.","journal-title":"Cancer Discov"},{"issue":"6","key":"4434_CR25","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","volume":"38","author":"J Van den Bossche","year":"2017","unstructured":"Van den Bossche J, O\u2019Neill LA, Menon D. Macrophage Immunometabolism: Where Are We (Going)? Trends Immunol. 2017;38(6):395\u2013406.","journal-title":"Trends Immunol"},{"issue":"8016","key":"4434_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41586-024-07501-1","volume":"630","author":"CT Stankey","year":"2024","unstructured":"Stankey CT, Bourges C, Haag LM, Turner-Stokes T, Piedade AP, Palmer-Jones C, et al. A disease-associated gene desert directs macrophage inflammation through ETS2. Nature. 2024;630(8016):447\u201356.","journal-title":"Nature"},{"issue":"3","key":"4434_CR27","doi-asserted-by":"publisher","first-page":"H613","DOI":"10.1152\/ajpheart.00220.2020","volume":"319","author":"J Shi","year":"2020","unstructured":"Shi J, Yang Y, Cheng A, Xu G, He F. Metabolism of vascular smooth muscle cells in vascular diseases. Am J Physiol Heart Circ Physiol. 2020;319(3):H613\u201331.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"4434_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00395-018-0698-6","volume":"113","author":"H Zhou","year":"2018","unstructured":"Zhou H, Li N, Yuan Y, Jin YG, Guo H, Deng W, et al. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target. Basic Res Cardiol. 2018;113(5):37.","journal-title":"Basic Res Cardiol"},{"issue":"12","key":"4434_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1161\/CIRCULATIONAHA.123.063332","volume":"148","author":"A Chakraborty","year":"2023","unstructured":"Chakraborty A, Li Y, Zhang C, Li Y, Rebello KR, Li S, et al. Epigenetic induction of smooth muscle cell phenotypic alterations in aortic aneurysms and dissections. Circulation. 2023;148(12):959\u201377.","journal-title":"Circulation"},{"issue":"11","key":"4434_CR30","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1161\/CIRCRESAHA.124.324323","volume":"134","author":"Y Wen","year":"2024","unstructured":"Wen Y, Liu Y, Li Q, Tan J, Fu X, Liang Y, et al. Spatiotemporal ATF3 expression determines VSMC fate in abdominal aortic aneurysm. Circ Res. 2024;134(11):1495\u2013511.","journal-title":"Circ Res"},{"issue":"1","key":"4434_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0753-3322(01)00154-8","volume":"56","author":"LP Shek","year":"2002","unstructured":"Shek LP, Lim DL. Thalidomide in Behcet\u2019s disease. Biomed Pharmacother. 2002;56(1):31\u20135.","journal-title":"Biomed Pharmacother"},{"key":"4434_CR32","doi-asserted-by":"publisher","first-page":"635663","DOI":"10.3389\/fphar.2021.635663","volume":"12","author":"R Bursi","year":"2021","unstructured":"Bursi R, Cafaro G, Perricone C, Riccucci I, Calvacchi S, Gerli R, et al. Contribution of Janus-kinase\/signal transduction activator of transcription pathway in the pathogenesis of vasculitis: a possible treatment target in the upcoming future. Front Pharmacol. 2021;12:635663.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4434_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrrheum.2015.167","volume":"12","author":"DM Schwartz","year":"2016","unstructured":"Schwartz DM, Bonelli M, Gadina M, O\u2019Shea JJ. Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nat Rev Rheumatol. 2016;12(1):25\u201336.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"4434_CR34","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/annrheumdis-2020-217307","volume":"79","author":"J Liu","year":"2020","unstructured":"Liu J, Hou Y, Sun L, Li C, Li L, Zhao Y, et al. A pilot study of tofacitinib for refractory Behcet\u2019s syndrome. Ann Rheum Dis. 2020;79(11):1517\u201320.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4434_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82(1):60\u201376.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"4434_CR36","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.27568","volume":"62","author":"D Saadoun","year":"2010","unstructured":"Saadoun D, Wechsler B, Desseaux K, Le Thi HD, Amoura Z, Resche-Rigon M, et al. Mortality in Behcet\u2019s disease. Arthritis Rheum. 2010;62(9):2806\u201312.","journal-title":"Arthritis Rheum"},{"issue":"15","key":"4434_CR37","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1093\/cvr\/cvad136","volume":"119","author":"M Bosman","year":"2023","unstructured":"Bosman M, Kruger D, Van Assche C, Boen H, Neutel C, Favere K, et al. Doxorubicin-induced cardiovascular toxicity: a longitudinal evaluation of functional and molecular markers. Cardiovasc Res. 2023;119(15):2579\u201390.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4434_CR38","first-page":"42","volume":"35","author":"T Zeng","year":"2019","unstructured":"Zeng T, Yuan J, Gan J, Liu Y, Shi L, Lu Z, et al. Thrombospondin 1 is increased in the aorta and plasma of patients with acute aortic dissection. Can J Cardiol. 2019;35(1):42\u201350.","journal-title":"Can J Cardiol"},{"issue":"6","key":"4434_CR39","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/CIRCRESAHA.118.313105","volume":"123","author":"Y Yamashiro","year":"2018","unstructured":"Yamashiro Y, Thang BQ, Shin SJ, Lino CA, Nakamura T, Kim J, et al. Role of thrombospondin-1 in mechanotransduction and development of thoracic aortic aneurysm in mouse and humans. Circ Res. 2018;123(6):660\u201372.","journal-title":"Circ Res"},{"issue":"12","key":"4434_CR40","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1161\/ATVBAHA.120.314913","volume":"40","author":"H Yang","year":"2020","unstructured":"Yang H, Zhou T, Sorenson CM, Sheibani N, Liu B. Myeloid-derived TSP1 (thrombospondin-1) contributes to abdominal aortic aneurysm through suppressing tissue inhibitor of metalloproteinases-1. Arterioscler Thromb Vasc Biol. 2020;40(12):e350\u201366.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"4434_CR41","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.117.312509","volume":"122","author":"C Cochain","year":"2018","unstructured":"Cochain C, Vafadarnejad E, Arampatzi P, Pelisek J, Winkels H, Ley K, et al. Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis. Circ Res. 2018;122(12):1661\u201374.","journal-title":"Circ Res"},{"issue":"2","key":"4434_CR42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.surg.2013.08.003","volume":"155","author":"JJ Stein","year":"2014","unstructured":"Stein JJ, Iwuchukwu C, Maier KG, Gahtan V. Thrombospondin-1-induced vascular smooth muscle cell migration and proliferation are functionally dependent on microRNA-21. Surgery. 2014;155(2):228\u201333.","journal-title":"Surgery"},{"issue":"2","key":"4434_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1083\/jcb.106.2.415","volume":"106","author":"RA Majack","year":"1988","unstructured":"Majack RA, Goodman LV, Dixit VM. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol. 1988;106(2):415\u201322.","journal-title":"J Cell Biol"},{"issue":"16","key":"4434_CR44","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.2174\/1389450121666200719010425","volume":"21","author":"J Charles","year":"2020","unstructured":"Charles J, Castellino FJ, Ploplis VA. Past and Present Behcet\u2019s disease animal models. Curr Drug Targets. 2020;21(16):1652\u201363.","journal-title":"Curr Drug Targets"},{"issue":"6","key":"4434_CR45","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s42255-022-00585-x","volume":"4","author":"Z Hu","year":"2022","unstructured":"Hu Z, Zhao TV, Huang T, Ohtsuki S, Jin K, Goronzy IN, et al. The transcription factor RFX5 coordinates antigen-presenting function and resistance to nutrient stress in synovial macrophages. Nat Metab. 2022;4(6):759\u201374.","journal-title":"Nat Metab"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04434-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04434-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04434-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:03:12Z","timestamp":1762963392000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04434-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4434"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04434-y","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Zhongshan Hospital Affiliated to Fudan University (B2013-115(3)) and complied with the 1975 Declaration of Helsinki. All study participants provided signed written informed consent. Animal studies were authorized by the Institutional Animal Care and Use Committee (IACUC) of Charles River Accelerator & Development Laboratories (Shanghai) Co., Ltd. (P202312250001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"631"}}